MYD88<sup>L265P</sup> Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
In IgM monoclonal gammopathies MYD88<sup>L265P</sup> is a prognostic and predictive biomarker of therapy response. MYD88<sup>L265P</sup> detection is mainly performed by allele-specific quantitative PCR (ASqPCR), however recently, droplet digital PCR (ddPCR) has been proved t...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/5/779 |